Audited Results of AstraZeneca Pharma India Ltd. Company

(Rs in Cr.)	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Operating Income	2,275.58	1,716.29	1,295.53	1,002.97	805.60
Manufacturing Expenses	2.88	5.30	4.87	5.54	8.10
Personnel Expenses	264.38	257.44	241.45	259.10	230.21
Selling Expenses	0	0	0	0	0
Administrative Expenses	364.32	233.93	267.99	210.79	166.04
Expenses Capitalised	0	0	0	0	0
Cost Of Sales	2,013.55	1,462.32	1,111.08	837.85	719.42
Operating Profit	262.03	253.97	184.45	165.12	86.18
Other Recurring Income	28.49	40.63	34.80	26.10	14.76
Adjusted PBDIT	290.52	294.60	219.25	191.22	100.94
Financial Expenses	4.49	1.46	1.20	0.63	0.95
Depreciation	28.58	39.99	14.94	16.26	16.95
Other Write offs	0	0	0	0	0
Adjusted PBT	257.45	253.15	203.11	174.33	83.04
Tax Charges	64.68	40.62	58.03	34.81	21.44
Adjusted PAT	192.77	212.53	145.08	139.52	61.60
Non Recurring Items	-9.69	-97.96	17.43	-42.84	-1.74
Other Non Cash adjustments	0	0	0	0	0
Reported Net Profit	187.52	115.74	161.51	99.29	61.60
Equity Dividend	80	60	40	20	5
Preference Dividend	0	0	0	0	0
Retained Earnings	735.80	632.72	578.15	455.64	378.96

Disclaimer: This is 3rd Party content/feed, viewers are requested to use their discretion and conduct proper diligence before investing, GoodReturns does not take any liability on the genuineness and correctness of the information in this article